Caxton Associates (New York)’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-938
Closed -$417K 685
2021
Q3
$417K Buy
938
+625
+200% +$280K 0.05% 240
2021
Q2
$147K Buy
+313
New +$187K 0.02% 436
2020
Q2
Sell
-156
Closed -$463K 644
2020
Q1
$463K Buy
+156
New +$254K 0.09% 173

Other funds holding VXX

Caxton Associates (New York)'s VXX Position: Q2 2021 in Review

Caxton Associates (New York) sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q2 2021, closing a stake of 27 shares — an estimated $16.1K sold.

Caxton Associates (New York) first reported a position in VXX in Q1 2021 and held it in 1 quarter. The position peaked at $19K in Q1 2021. 114 funds tracked by Wall St. Rank hold VXX as of Q2 2021.

  • Caxton Associates (New York) reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q2 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 27 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2021, an estimated $16.1K.
  • Caxton Associates (New York) first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $19K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.